PBX-001
/ PinotBio
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
October 27, 2023
‘LegoChem-Aimed-Pino’ Bio, what is the technology of the three ADC biotech companies? [ADC Development Before] Below [Google translation]
(eDaily)
- "...the company is conducting preclinical trials for solid cancer for the ADC candidate 'PBX-001', which is a TROP2 antibody conjugated with a self-developed toxin. The goal is for the substance to enter clinical trials in 2025."
New trial • Oncology • Solid Tumor
1 to 1
Of
1
Go to page
1